Response to Commentary "Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes"

We wish to clarify key points raised in a recent commentary (Asgari, 2016) about our report on survival outcomes after multiple primary invasive melanomas (Youlden et al., 2016) published in the November 2016 issue of The Journal of Investigative Dermatology.